Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial

Affiliations

• ¹ Division of Hematology/Oncology/Blood and Marrow Transplantation, Children's Mercy Kansas City, Kansas City, MO. eguest@cmh.edu.
• ² Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL.
• ³ Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO.
• ⁴ Texas Children's Hospital, Houston, TX.
• ⁵ Department of Genetics, University of Alabama at Birmingham, Birmingham, AL.
• ⁶ The Ohio State University Comprehensive Cancer Center, Columbus, OH.
• ⁷ Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN.
• ⁸ U.S. Army Medical Research and Materiel Command, Fort Detrick, MD.
• ⁹ Division of Pediatric Hematology/Oncology, University of Texas Southwestern School of Medicine, Dallas, TX.
• ¹⁰ Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY.
• ¹¹ Departments of Pathology and Oncology, Johns Hopkins University, Baltimore, MD.
• ¹² Department of Pediatrics, Benioff Children's Hospital in the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
• ¹³ Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
• ¹⁴ Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.